Publicações

Development of Dl1.72, a Novel Anti-Dll1 Antibody with Anti-Tumor Efficacy Against Estrogen Receptor-Positive Breast Cancer

AuthID
P-00V-CD5

Author(s)

Silva, G

Sales Dias, J

Casal, D

Alves, S

Domenici, G

Barreto, C

Matos, C

Lemos, AR

Matias, AT

Kucheryava, K

[+1]·

Moita, MR

Braga, S

Sousa, PMF

Barbas, A

Tipo de Documento

Article

Year published

2021

Publicado

in CANCERS

Volume: 13, Número: 16, Páginas: 4074 (20)

Indexing

Wos^®

Scopus^®

Crossref^®4

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.3390/cancers13164074

SCOPUS: 2-s2.0-85112348312

Wos: WOS:000689049500001

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Silva, G;	2	Sales Dias, J;	3	Casal, D;
4	Alves, S;	5	Domenici, G;	6	Barreto, C;
7	Matos, C;	8	Lemos, AR;	9	Matias, AT;
10	Kucheryava, K;	11	Ferreira, A;	12	Moita, MR;
13	Braga, S;	14	Brito, C;	15	Cabral, MG;
16	Casalou, C;	17	Barral, DC;	18	Sousa, PMF;
19	Videira, PA;	20	Bandeiras, TM;	21	Barbas, A;

Development of Dl1.72, a Novel Anti-Dll1 Antibody with Anti-Tumor Efficacy Against Estrogen Receptor-Positive Breast Cancer

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Development of Dl1.72, a Novel Anti-Dll1 Antibody with Anti-Tumor Efficacy Against Estrogen Receptor-Positive Breast Cancer

Links Úteis

Ajuda